SWK Acquisition and Platform Expansion
Closed SWK transaction (April 6) which meaningfully reconstructed the portfolio, producing a pro forma portfolio of $1.1 billion, increasing diversification and strengthening origination capabilities through BC Partners Credit integration and new healthcare expertise (JD Thomas).
Increased Healthcare Exposure
Health care and life sciences now comprise 32% of the portfolio at fair value (and ~30% of the debt portfolio), improving sector diversification and expected to contribute positively to return profile over the year.
Improved Portfolio Concentration
Top 10 investments concentration reduced from 54% pre-SWK to 43% post-transaction, lowering single-name concentration risk and average loan size (reduced by 11% pro forma).
Liquidity and Capital Actions
Total available liquidity of $372.3 million as of 03/31/2026 (including cash) and $370 million borrowing capacity under KeyBank; announced $15 million share repurchase authorization and Board-declared regular distribution of $0.33 per share.
Stable Debt Portfolio Yield and Realized Gains
Dollar-weighted average annualized yield on the debt portfolio remained strong at 14.2% (consistent with 2025), and the quarter included a net realized gain on investments of $1.3 million versus a realized loss of $0.38 million a year earlier.
Software Portfolio Fundamentals
Software portfolio shows resilience: 62% of companies cash flow positive, 100% of loans have financial covenants, weighted average fair value as percent of cost (ex-nonaccruals) 97%, and 94% of software loans sponsored; portfolio is 98% first-lien overall.
Dividend and Spillover Income
Reported net investment income per share of $0.29 and declared a base dividend of $0.33 per share; reported spillover income of approximately $0.65 per share to support future distributions.